Outil pour la communication comportementale et sociale dans le cadre de la riposte aux flambées épidémiques
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...children living in areas of moderate to high malaria transmission. It also incorporates findings from the evaluation of the WHO-coordinated Malaria Vaccine Implementation Programme (MVIP), recommended by SAGE and MPAG in 2015, and from additional studies since 2015.
This paper does not include findings on vaccine efficacy in infants first vaccinated at 6–12 weeks of age. Because of the lower vaccine efficacy observed in this age category, WHO did not recommend pilot implementation or RTS,S/AS01 vaccine introduction for these young infants. Recommendations2 on the use of RTS,S/AS01 vaccine were discussed by SAGE and MPAG during a joint session in October 2021; evidence presented at the meeting can be accessed at https://terrance.who.int/mediacentre/data/ sage/SAGE_eYB_Oct2021.pdf
more
Orientations provisoires 19 juillet 2021
Rapport biennal de la directrice régionale
République de Guinée . Rapport final
Étude menée dans le cadre du Projet "Ville Handicap" dans les communes d'Antsiranana et de Mahajanga
La communication efficace sur les risques liés au virus Ebola nécessite à la fois du respect et
de la transparence et demeure plus vitale que jamais.